Clinical Trial Update: A Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular Dysfunction [Phase 2]

View source ↗

Summary

A Phase 2 open-label, randomized cross-over trial evaluated whether acetazolamide, a carbonic anhydrase inhibitor, can affect sleep apnea–associated hypertensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obstructive Sleep Apnea
• Sleep-disordered Breathing

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: Göteborg University | Conditions: Obstructive Sleep Apnea, Sleep-Disordered Breathing | Phase 2 | Status: COMPLETED